Patents by Inventor Akito MINAMIZONO
Akito MINAMIZONO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230414578Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and one or more selected from the group consisting of a metal oxide, a dihydric alcohol, an ester species and a silicic acid compound and which has excellent storage stability. The pharmaceutical composition includes the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) one or more selected from the group consisting of the following components (B-1) to (B-4): (B-1) a metal oxide; (B-2) a dihydric alcohol; (B-3) an ester species; and (B-4) a silicic acid compound, with component (A) and component (B) being substantially in non-contact with each other.Type: ApplicationFiled: September 11, 2023Publication date: December 28, 2023Applicant: KOWA COMPANY, LTD.Inventor: Akito MINAMIZONO
-
Patent number: 11759456Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition contains pemafibrate, a salt thereof or a solvate thereof in an amount of 0.017 to 4.2 mass % in terms of a free form of pemafibrate with respect to the total mass of the pharmaceutical composition.Type: GrantFiled: June 29, 2018Date of Patent: September 19, 2023Assignee: KOWA COMPANY, LTD.Inventors: Shin Sugimoto, Akito Minamizono
-
Patent number: 11730719Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and has excellent stability. A pharmaceutical composition is provided containing pemafibrate, a salt thereof or a solvate thereof and having a moisture content of 2.4 mass % or less.Type: GrantFiled: February 2, 2022Date of Patent: August 22, 2023Assignee: KOWA COMPANY, LTD.Inventors: Shin Sugimoto, Akito Minamizono
-
Publication number: 20230190712Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided to contain the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) one or more selected from the group consisting of the following components (B-1) to (B-6): (B-1) a cellulose ether species; (B-2) a starch species; (B-3) a povidone species; (B-4) a silicic acid compound; (B-5) a polyhydric alcohol; and (B-6) an alkyl sulfate ester.Type: ApplicationFiled: February 22, 2023Publication date: June 22, 2023Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO
-
Patent number: 11419855Abstract: Provided is a novel technique for improving storage stability of a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and a cellulose species. A pharmaceutical preparation obtained by storing a pharmaceutical composition containing the following components (A) and (B) in a tight package: (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a cellulose species.Type: GrantFiled: June 29, 2018Date of Patent: August 23, 2022Assignee: KOWA COMPANY, LTD.Inventors: Shin Sugimoto, Akito Minamizono
-
Patent number: 11406621Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided containing the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a disaccharide species.Type: GrantFiled: June 29, 2018Date of Patent: August 9, 2022Assignee: KOWA COMPANY, LTD.Inventors: Shin Sugimoto, Akito Minamizono
-
Patent number: 11344535Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent storage stability. The pharmaceutical composition is provided to contain pemafibrate, a salt thereof or a solvate thereof, wherein a pH value of a solution produced by dissolving or dispersing the pharmaceutical composition in water is 7 or more.Type: GrantFiled: June 29, 2018Date of Patent: May 31, 2022Assignee: KOWA COMPANY, LTD.Inventors: Yuki Kuroiwa, Akito Minamizono
-
Publication number: 20220151996Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and has excellent stability. A pharmaceutical composition is provided containing pemafibrate, a salt thereof or a solvate thereof and having a moisture content of 2.4 mass % or less.Type: ApplicationFiled: February 2, 2022Publication date: May 19, 2022Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO
-
Patent number: 11298340Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and has excellent stability. A pharmaceutical composition is provided containing pemafibrate, a salt thereof or a solvate thereof and having a moisture content of 2.4 mass % or less.Type: GrantFiled: June 29, 2018Date of Patent: April 12, 2022Assignee: KOWA COMPANY, LTD.Inventors: Shin Sugimoto, Akito Minamizono
-
Publication number: 20220096443Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided to contain the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) one or more selected from the group consisting of the following components (B-1) and (B-7): (B-1) an alkylcellulose and a salt thereof; and a (meth)acrylic acid-based polymer.Type: ApplicationFiled: December 27, 2019Publication date: March 31, 2022Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO, Chisa NISHIDA
-
Publication number: 20200222370Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent storage stability. The pharmaceutical composition is provided to contain pemafibrate, a salt thereof or a solvate thereof, wherein a pH value of a solution produced by dissolving or dispersing the pharmaceutical composition in water is 7 or more.Type: ApplicationFiled: June 29, 2018Publication date: July 16, 2020Applicant: KOWA COMPANY, LTD.Inventors: Yuki KUROIWA, Akito MINAMIZONO
-
Publication number: 20200179346Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition contains pemafibrate, a salt thereof or a solvate thereof in an amount of 0.017 to 4.2 mass % in terms of a free form of pemafibrate with respect to the total mass of the pharmaceutical composition.Type: ApplicationFiled: June 29, 2018Publication date: June 11, 2020Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO
-
Publication number: 20200155514Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided containing the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a disaccharide species.Type: ApplicationFiled: June 29, 2018Publication date: May 21, 2020Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO
-
Publication number: 20200129483Abstract: Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided to contain the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) one or more selected from the group consisting of the following components (B-1) to (B-6): (B-1) a cellulose ether species; (B-2) a starch species; (B-3) a povidone species; (B-4) a silicic acid compound; (B-5) a polyhydric alcohol; and (B-6) an alkyl sulfate ester.Type: ApplicationFiled: June 29, 2018Publication date: April 30, 2020Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO
-
Publication number: 20200121650Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and has excellent stability. Apharmaceutical composition is provided containing pemafibrate, a salt thereof or a solvate thereof and having a moisture content of 2.4 mass % or less.Type: ApplicationFiled: June 29, 2018Publication date: April 23, 2020Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO
-
Publication number: 20200121648Abstract: Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and one or more selected from the group consisting of a metal oxide, a dihydric alcohol, an ester species and a silicic acid compound and which has excellent storage stability. The pharmaceutical composition includes the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) one or more selected from the group consisting of the following components (B-1) to (B-4): (B-1) a metal oxide; (B-2) a dihydric alcohol; (B-3) an ester species; and (B-4) a silicic acid compound, with component (A) and component (B) being substantially in non-contact with each other.Type: ApplicationFiled: June 29, 2018Publication date: April 23, 2020Applicant: KOWA COMPANY, LTD.Inventor: Akito MINAMIZONO
-
Publication number: 20200121649Abstract: Provided is a novel technique for improving storage stability of a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and a cellulose species. A pharmaceutical preparation obtained by storing a pharmaceutical composition containing the following components (A) and (B) in a tight package: (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a cellulose species.Type: ApplicationFiled: June 29, 2018Publication date: April 23, 2020Applicant: KOWA COMPANY, LTD.Inventors: Shin SUGIMOTO, Akito MINAMIZONO